Brief: Fusion Antibodies Says CLD Project Expected To Generate $250,000 Revenue By End Of 2025
27/02/2025 07:32
Feb 27 (Reuters) - Fusion Antibodies PLC FAB.L: FUSION ANTIBODIES - CONTRACT WIN FUSION ANTIBODIES PLC - SELECTED FOR NEW CELL LINE DEVELOPMENT PROJECT FUSION ANTIBODIES PLC - CLD PROJECT EXPECTED TO GENERATE $250,000 REVENUE BY END OF 2025 Source text: ID:nRSa6084Ya Further company coverage: FAB.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM